Bradford Institute for Health Research are proud to announce a Global first in Immedcia phase 3 paediatric study for pegzilarginase in arginase 1 deficiency (ARG1-D)
ARG1-D Is a rare inherited disease affecting growth, learning and health. Pegzilarginase has not previously been studied in patients below 2 years of age. Our patient recruited into the trial is receiving weekly treatment through the study at St Lukes hospital and hopefully it will have a substantial impact on the course of their disease […]
Bradford to receive part of £100 million investment boost to unlock cutting-edge treatments
• Bradford is set to be one of 20 new research hubs (Commercial Research Delivery Centres – CRDCs) to be set up across UK to accelerate research into the next generation of treatments.• Funded through £100 million of private investment from pharmaceutical companies, boosting economic growth• New centres will shift research from big hospitals into […]
Bradford researchers shape global policies on improving child health in their first 2,000 days of life
RESEARCHERS from Bradford are playing a key role in inspiring new guidance to protect and enhance children’s health and wellbeing all over the world. The landmark study, Born in Bradford (BiB), has already worked with respected medical journal The Lancet to shape best practice for a child’s first 1,000 days. Recommended policies focused on overall […]
£1.5m grants boost City of Research as UK’s leading health research hub
HEALTH researchers in Bradford can look forward to a double boost after being awarded twin grants worth almost £1.5m, further securing the city’s role at the national forefront of vital medical studies and clinical trials and its reputation as a City of Research. The Bradford Institute for Health Research (BIHR), part of Bradford Teaching Hospitals […]
